Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-130022

Options or other derivatives

  • Director acquired 109,561 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clancy Paul J · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-10-26 Grant or award : show line 1 in the form Stock Option (right to buy) +44,033 44,033 D
2021-10-26 Grant or award : show line 2 in the form Stock Option (right to buy) +65,528 65,528 D
Loading xslF345X03/tm2130646-19_4seq1.xml…